Skip to main content

Vaccine tides turning in SSA? Evergrande reverberations

This week brought the prospect of an improvement in Sub-Saharan Africa’s vaccine supplies, but the region is still likely to struggle to catch up with the rest of the world in the global vaccination race. Meanwhile, although we expect the fallout from the Evergrande saga to be limited, the region’s metal producers like South Africa are exposed to weakness in China’s property sector. Finally, there has been some momentum towards a debt restructuring deal for Ethiopia, but this will probably be difficult to thrash out.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.

By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.